Anthropometric Measurements as Predictors of Low Birth Weight Among Tanzanian Neonates: A Hospital-Based Study
November 7, 2025
Free CME credits
Both our subscription plans include Free CME/CPD AMA PRA Category 1 credits.
Brand Name :
Cimzia
Synonyms :
Class :
TNF Inhibitors, Immunosuppressants
Brand Name :
Cimzia
Synonyms :
Class :
TNF Inhibitors, Immunosuppressants
Dosage forms & Strengths:
Adult:
Injectable solution:
200 mg/ml
400
mg
Solution
Subcutaneous (SC)
every 2 weeks
400
mg
Solution
Subcutaneous (SC)
every 2 weeks
400
mg
Solution
Subcutaneous (SC)
every 2 weeks
Safety and efficacy are not seen in pediatrics
Safety and efficacy are not seen in pediatrics:
certolizumab pegol, through pharmacodynamic antagonism, reduces the impact of the live rotavirus oral vaccine on the body
when both drugs are combined, the metabolism of paclitaxel increases when compared with certolizumab pegol
when both the drugs are combined, the metabolism of carmustine increases
increases the risk of serious infection due to immunosuppression
It may diminish the therapeutic efficacy when combined with pegloticase
it may enhance the adverse effects when combined with aducanumab
certolizumab pegol may decrease the excretion rate of almasilate, leading to higher serum levels
pneumococcal vaccine 13-valent
certolizumab pegol diminishes the efficacy of the 13-valent pneumococcal vaccine through pharmacodynamic antagonism
>10%:
Headache
Nasopharyngitis
Nausea
1-10%:
UTI
Arthralgia
Serious infections
Frequency undefined:
Opportunistic infections
Lupus-like syndrome
Malignancies
Immunogenicity
Lymphatic system disorder
Cardiac disorder
Ocular disorder
Hypersensitivity
Psychiatric disorder
Renal disorder
Menstrual disorder
Skin & subcutaneous disorder
Certolizumab pegol is contraindicated in patients hypersensitive to the formulation’s active ingredient and other excipients.
Pregnancy consideration:
The data available is insufficient
Breastfeeding warnings:
The drug can be used in lactating women.
Pregnancy category:
Patient information leaflet
Generic Name: certolizumab pegol
Pronounced: cer-to-LIZ-u-mab-PEG-ol
Why do we use certolizumab pegol?
Certolizumab pegol belongs to the category of immunosuppressants. It treats Crohn’s disease, psoriatic arthritis, ankylosing spondylitis, spondylarthritis, plaque psoriasis, and rheumatoid arthritis.
Both our subscription plans include Free CME/CPD AMA PRA Category 1 credits.
On course completion, you will receive a full-sized presentation quality digital certificate.
A dynamic medical simulation platform designed to train healthcare professionals and students to effectively run code situations through an immersive hands-on experience in a live, interactive 3D environment.
When you have your licenses, certificates and CMEs in one place, it's easier to track your career growth. You can easily share these with hospitals as well, using your medtigo app.
